Chemomab Therapeutics Ltd. Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
Chemomab Therapeutics Ltd. (CMMB) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of $8.65 million as of 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2019-04-24
- 2018-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $8.65M.
- 2017-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $7.04M.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2018-12-31 | $8.65M 20-F · filed 2019-04-24 |
| 2017-12-31 | $7.04M 20-F · filed 2019-04-24 |